Published: Vol 4, Iss 5, Mar 5, 2014 DOI: 10.21769/BioProtoc.1055 Views: 11134
Reviewed by: Anonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
Preparation of Parasite Protein Extracts and Western Blot Analysis
Arlett Heiber and Tobias Spielmann
Jun 5, 2014 25215 Views
Construction of a Highly Diverse mRNA Library for in vitro Selection of Monobodies
Taishi Kondo [...] Hiroshi Murakami
Aug 20, 2021 2837 Views
An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2
Claire Baine [...] Jennifer Serwanga
Dec 20, 2023 2220 Views
Abstract
Upon rupture of Plasmodium falciparum (P. falciparum) schizonts in vitro (an event known as egress), merozoites are released into the culture medium. The merozoites invade fresh red blood cells, a process that involves shedding of a microneme protein called apical membrane antigen-1 (AMA1) from the merozoite surface. This shedding, which takes place even in the absence of invasion, is therefore a surrogate marker for the degree of egress taking place in a culture, and can be measured using a specific capture ELISA to quantify AMA1 levels in culture supernatants (Collins et al., 2013). The assay uses a monoclonal antibody specific for AMA1 (called 4G2dc1) (Kocken et al., 1998; Collins et al., 2009) to capture and immobilize the protein from culture supernatants, then uses a specific rabbit polyclonal antiserum to detect the immobilized antigen. A phosphatase-conjugated goat anti-rabbit antibody is finally used to quantify the binding of the second antibody. Egress is absolutely dependent upon the activity of a parasite cGMP-dependent protein kinase, PKG, and so is influenced by levels of intracellular cGMP (Collins et al., 2013). This is regulated by the interplay between guanylate cyclases and phosphodiesterases. The latter enzymes may also degrade cAMP, so it may also be informative to measure intracellular cAMP levels.
Materials and Reagents
Equipment
Procedure
Recipes
Acknowledgments
This method is adapted from an original method described in Collins et al. (2013). The authors are grateful to Alan Thomas (Biomedical Primate Research Centre, Rijswijk, The Netherlands) for the gift of monoclonal antibody 4G2dc1. This work was supported by the UK Medical Research Council (U117532063), and received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095 (EviMalAR).
References
Article Information
Copyright
© 2014 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
Category
Microbiology > Microbial biochemistry > Protein
Biochemistry > Protein > Immunodetection
Biochemistry > Other compound > cAMP
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link